Antiaging Quantum Living Inc.
AAQL
$0.57
-$0.43-42.77%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 125.29% | 44.19% | -- | 2,352.38% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 125.29% | 44.19% | -- | 2,352.38% | -- |
| Cost of Revenue | 356.25% | 28,250.00% | -- | 550.00% | -- |
| Gross Profit | 104.35% | 16.25% | -- | 2,614.55% | -- |
| SG&A Expenses | 5.36% | -10.32% | -62.61% | 239.28% | 1,361.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.01% | 3.27% | 78.61% | 241.68% | 1,420.08% |
| Operating Income | 74.12% | 35.39% | 31.47% | -104.74% | -710.66% |
| Income Before Tax | 74.10% | 40.44% | 31.40% | -33.06% | -710.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 68.84% | 37.63% | 31.40% | -33.06% | -710.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.84% | 37.63% | 31.40% | -33.06% | -710.25% |
| EBIT | 74.12% | 35.39% | 31.47% | -104.74% | -710.66% |
| EBITDA | 95.08% | 47.08% | 43.79% | -67.63% | -502.06% |
| EPS Basic | 68.18% | 38.03% | 31.03% | -34.38% | -725.00% |
| Normalized Basic EPS | 73.17% | 40.00% | 32.73% | -35.00% | -720.00% |
| EPS Diluted | 68.18% | 38.03% | 31.03% | -34.38% | -725.00% |
| Normalized Diluted EPS | 73.17% | 40.00% | 32.73% | -35.00% | -720.00% |
| Average Basic Shares Outstanding | 0.15% | 0.00% | 0.00% | 0.00% | -0.15% |
| Average Diluted Shares Outstanding | 0.15% | 0.00% | 0.00% | 0.00% | -0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |